Jump to ContentJump to Main Navigation
FDA in the Twenty-First CenturyThe Challenges of Regulating Drugs and New Technologies$
Users without a subscription are not able to see the full content.

Holly Fernandez Lynch and I. Glenn Cohen

Print publication date: 2015

Print ISBN-13: 9780231171182

Published to Columbia Scholarship Online: May 2016

DOI: 10.7312/columbia/9780231171182.001.0001

Show Summary Details
Page of

PRINTED FROM COLUMBIA SCHOLARSHIP ONLINE (www.columbia.universitypressscholarship.com). (c) Copyright University of Minnesota Press, 2021. All Rights Reserved. An individual user may print out a PDF of a single chapter of a monograph in CUPSO for personal use.date: 29 July 2021

The Crime of Being in Charge

The Crime of Being in Charge

Executive Culpability and Collateral Consequences

Chapter:
(p.146) Chapter Eight The Crime of Being in Charge
Source:
FDA in the Twenty-First Century
Author(s):

Katrice Bridges Copeland

Publisher:
Columbia University Press
DOI:10.7312/columbia/9780231171182.003.0011

This chapter argues that pharmaceutical executives, who are charged as responsible corporate officers and receive minor criminal penalties, should not face the harsh civil remedy of exclusion from participation in federal health care programs for lengthy periods of time without a showing of moral blameworthiness.

Keywords:   Fraud, responsible corporate officer, Park doctrine, Exclusion, collateral consequences, moral blame

Columbia Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs, and if you can't find the answer there, please contact us .